PEA-OXA Mitigates Oxaliplatin-Induced Painful Neuropathy through NF-κB/Nrf-2 Axis

PEA-OXA Mitigates Oxaliplatin-Induced Painful Neuropathy through NF-κB/Nrf-2 Axis

Chemotherapy-induced neuropathy is a common, dose-dependent adverse effect of several antineoplastics, such as oxaliplatin (L-OHP). The aim of the present work was to evaluate the potential beneficial effects of 2-pentadecyl-2-oxazoline (PEA-OXA) in a murine model of oxaliplatin-induced peripheral n...

Full description

Bibliographic Details
Main Authors:	Michela Campolo, Marika Lanza, Irene Paterniti, Alessia Filippone, Alessio Ardizzone, Giovanna Casili, Sarah A. Scuderi, Caterina Puglisi, Marzia Mare, Lorenzo Memeo, Salvatore Cuzzocrea, Emanuela Esposito
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	International Journal of Molecular Sciences
Subjects:	palmitoylethanolamide ultramicronized (PEAum) 2-pentadecyl-2-oxazoline (PEA-OXA) oxaliplatin (L-OHP) pain dorsal root ganglia (DRG)
Online Access:	https://www.mdpi.com/1422-0067/22/8/3927

Similar Items

Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach
by: Alessio Filippo Peritore, et al.
Published: (2021-05-01)

N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion
by: Daniela Impellizzeri, et al.
Published: (2019-05-01)

Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome
by: Chirchiglia D, et al.
Published: (2019-02-01)

Ultramicronized Palmitoylethanolamide in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
by: Ramona D’Amico, et al.
Published: (2021-10-01)

An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events
by: Marika Cordaro, et al.
Published: (2020-03-01)

Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation
by: Giovanna Casili, et al.
Published: (2020-10-01)

Oxaliplatin treatment changes the function of sensory nerves in rats
by: Shohei Yamamoto, et al.
Published: (2016-04-01)

Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
by: Stochino Loi E, et al.
Published: (2019-08-01)

PEALut in the Dietary Management of Patients with Acute Ischemic Stroke: A Prospective Randomized Controlled Clinical Trial
by: Massimo Bonzanino, et al.
Published: (2024-01-01)

Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
by: Annalisa Noce, et al.
Published: (2021-04-01)

2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play
by: R. Infantino, et al.
Published: (2022-12-01)

Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury
by: Michela Campolo, et al.
Published: (2021-08-01)

Antioxidant and Neuroprotective Effect of a Grape Pomace Extract on Oxaliplatin-Induced Peripheral Neuropathy in Rats: Biochemical, Behavioral and Histopathological Evaluation
by: Chryssa Bekiari, et al.
Published: (2022-05-01)

Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer
by: Xiao-Yin Zhao, et al.
Published: (2022-10-01)

Carbapenemase OXA-423: A Novel OXA-23 Variant in Acinetobacter baumannii
by: Yang Z, et al.
Published: (2020-11-01)

Duloxetine, a Balanced Serotonin-Norepinephrine Reuptake Inhibitor, Improves Painful Chemotherapy-Induced Peripheral Neuropathy by Inhibiting Activation of p38 MAPK and NF-κB
by: Jing Meng, et al.
Published: (2019-04-01)

Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
by: Paterniti Irene, et al.
Published: (2013-02-01)

Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush
by: Enrico Gugliandolo, et al.
Published: (2018-09-01)

Oxaliplatin-Associated Amaurosis Fugax
by: Kimitoshi Kubo, et al.
Published: (2021-06-01)

Complete sequence of carbapenem-resistant Ralstonia mannitolilytica clinical isolate co-producing novel class D β-lactamase OXA-1176 and OXA-1177 in Japan
by: Wataru Hayashi, et al.
Published: (2024-04-01)

Early Stimulation of TREK Channel Transcription and Activity Induced by Oxaliplatin-Dependent Cytosolic Acidification
by: Marianna Dionisi, et al.
Published: (2020-09-01)

METTL3 promotes drug resistance to oxaliplatin in gastric cancer cells through DNA repair pathway
by: Yi Wang, et al.
Published: (2023-09-01)

First report of carbapenemase OXA-181-producing Serratia marcescens
by: Aziza Messaoudi, et al.
Published: (2021-09-01)

lncRNA MCF2L-AS1/miR-105/ IL-1β Axis Regulates Colorectal Cancer Cell Oxaliplatin Resistance
by: Cai M, et al.
Published: (2021-11-01)

2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation
by: Stefania Petrosino, et al.
Published: (2017-05-01)

Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury
by: Rosalia eCrupi, et al.
Published: (2016-03-01)

Long-chain cyclic acetals of glycerol: metabolism of the stereomeric 1,3-dioxanes and 1,3-dioxolanes in myelinating rat brain
by: K.L. Su, et al.
Published: (1974-01-01)

Glimpse into the genome sequence of a multidrug-resistant Acinetobacter pittii ST950 clinical isolate carrying the blaOXA-72 and blaOXA-533 genes in China
by: Zhi Ruan, et al.

Establishment of the menthol test as a clinical evaluation method for oxaliplatin-induced neuropathy
by: Yeongcheol Cheong, et al.
Published: (2022-08-01)

Emergence of OXA-484, an OXA-48–type beta-lactamase, in Switzerland
by: Jacqueline Findlay, et al.
Published: (2023-03-01)

Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-<span style="font-variant: small-caps">l</span>-Carnitine on Experimental Model of Inflammatory Pain
by: Alessio Ardizzone, et al.
Published: (2021-02-01)

L’Option Hauts Plateaux-Sud Comme Outil de Développement Durable du Territoire Algérien
by: Halim Zıdelkhıl, et al.
Published: (2020-06-01)

Oxacillinase (OXA)-producing Acinetobacter baumannii in Brazil: clinical and environmental impact and therapeutic options
by: Micheli Medeiros, et al.
Published: (2013-12-01)

Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia
by: Elizabeth Pan, et al.
Published: (2018-12-01)

بررسی شیوع بتالاکتامازهای وسیع الطیف OXA-2 و OXA-10 در سویه های اسینتوباکتر ایزوله شده از بیماران شهر زاهدان
by: محمد بکاییان, et al.
Published: (2016-03-01)

Emergence of carbapenem-resistant enterobacterales co-harboring bla OXA−78 and bla OXA−58 from India
by: Bhaskar Jyoti Das, et al.
Published: (2023-09-01)

Environmental Risk Assessment of Oxaliplatin Exposure on Early Life Stages of Zebrafish (<i>Danio rerio</i>)
by: Davide Di Paola, et al.
Published: (2022-02-01)

The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates
by: Bojana Lukovic, et al.
Published: (2020-07-01)

Adsorption of Oxaliplatin by Hydroxyapatite
by: Papageorgiou A., et al.
Published: (2007-12-01)

Rapid control of a hospital-wide outbreak caused by extensively drug-resistant OXA-72-producing Acinetobacter baumannii
by: Wei-Ru Lin, et al.
Published: (2011-06-01)